Keyphrases
Hepatocellular Carcinoma
100%
Taiwan
52%
Confidence Interval
31%
Hazard Ratio
23%
Hepatitis C Virus
23%
Mesenchymal Stem Cells
21%
Hepatocellular Carcinoma Patients
20%
Cirrhosis
18%
Endothelial Progenitor Cells
18%
Overall Survival
17%
Chronic Hepatitis C
17%
Hepatitis C
16%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
15%
Transarterial Chemoembolization
15%
Migraine
15%
Risk Factors
15%
Hepatitis B Virus
14%
Human Mesenchymal Stem Cells (hMSCs)
14%
Head-and-neck Cancer
14%
Reversible Cerebral Vasoconstriction Syndrome
13%
Hepatitis B Surface Antigen (HBsAg)
13%
Chronic Hepatitis B
13%
Human Immunodeficiency Virus Type 1 (HIV-1)
13%
National Cohort Study
13%
Clinical Outcomes
13%
Human Endothelial Progenitor Cells
12%
Prognostic Factors
12%
Epithelial-mesenchymal Transition
12%
Ruptured Abdominal Aortic Aneurysm (rAAA)
12%
Taiwanese
12%
Multivariate Analysis
11%
Albumin-bilirubin Grade
11%
Radiofrequency Ablation
11%
High Risk
10%
Stem Cells
9%
Chemotherapy
9%
Surgical Resection
9%
Direct-acting Antivirals
9%
Sustained Virological Response
9%
Chronic Migraine
9%
Chronic Kidney Disease
9%
Tumor
9%
Odds Ratio
9%
Alpha-fetoprotein
8%
Chronic Hepatitis B Patients
8%
Hepatitis C Virus Infection
8%
Taipei
8%
Cardiovascular Events
8%
Hepatitis B e Antigen (HBeAg)
8%
Mesenchymal Stromal Cells
8%
Headache
8%
Cancer Cells
8%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
7%
Macrophages
7%
Metastasis
7%
Osteogenic Differentiation
7%
Barcelona Clinic Liver Cancer
7%
Angiogenesis
7%
Advanced Hepatocellular Carcinoma
7%
Immune Checkpoint Inhibitors
7%
Arteriovenous Fistula
7%
Coronary Artery Bypass Grafting
7%
Gag-Pol
7%
Acute Myocardial Infarction
7%
Liver
7%
Hepatitis B
6%
Inflammation
6%
Liver Cirrhosis
6%
Hepatocellular Carcinoma Risk
6%
COVID-19
6%
Propensity Score Analysis
6%
Cirrhotic Patients
6%
Neovascularization
6%
Ischemic Stroke
6%
Oxidative Stress
6%
Cell Function
6%
All-cause Mortality
6%
Major Adverse Cardiovascular Events
6%
Percutaneous Coronary Intervention
6%
MELD Score
6%
Virus
6%
Meta-analysis
6%
Coronary Artery Disease
6%
Performance Status
6%
Ischemia
6%
Unresectable Hepatocellular Carcinoma
5%
Treatment Outcome
5%
Cox Proportional Hazards Model
5%
Overexpression
5%
Computed Tomography
5%
Tumor Recurrence
5%
Hemodialysis Patients
5%
Adjusted Hazard Ratio
5%
Non-diabetic
5%
Tumor Necrosis Factor-α
5%
Serum Levels
5%
AIDS/HIV
5%
Antiretroviral Therapy
5%
Patients with Coronary Artery Disease
5%
Cardiovascular Disease
5%
Medicine and Dentistry
Hepatocellular Carcinoma
97%
Neoplasm
23%
Liver Cirrhosis
19%
Hazard Ratio
18%
Surgery
17%
Hepatitis B Virus
17%
Mesenchymal Stem Cell
17%
Overall Survival
16%
Hepatitis C Virus
16%
Transcatheter Arterial Chemoembolization
15%
Endothelial Progenitor Cell
15%
Cardiovascular System
14%
Diseases
14%
Coronary Artery Disease
13%
Chronic Hepatitis C
13%
Chronic Hepatitis B
12%
Bilirubin
12%
Cohort Analysis
11%
Hepatitis C
11%
Malignant Neoplasm
11%
Prevalence
10%
Proportional Hazards Model
10%
Infection
9%
Liver Cancer
9%
Diabetes Mellitus
9%
Migraine
9%
Radiofrequency Ablation
9%
Chronic Kidney Disease
9%
Hemodialysis
9%
Head and Neck Squamous Cell Carcinoma
8%
Prognostic Factor
8%
Multivariate Analysis
8%
Headache
8%
Aortic Dissection
8%
Hepatitis B
8%
Metastatic Carcinoma
8%
Recurrent Disease
8%
In Vitro
8%
Odds Ratio
7%
Abdominal Aortic Aneurysm
7%
Antiviral Therapy
7%
Arteriovenous Fistula
7%
Cancer Staging
7%
Cardiovascular Disease
7%
Platelet
7%
Endovascular Aneurysm Repair
7%
Cancer
6%
Survival Rate
6%
Head and Neck Cancer
6%
Reversible Cerebral Vasoconstriction Syndrome
6%
Coronary Artery Bypass Graft
6%
Fibrosis
6%
Stem Cell
6%
Biological Marker
6%
Computer Assisted Tomography
6%
Angiogenesis
6%
Acute Kidney Injury
6%
Percutaneous Coronary Intervention
6%
Stent-Graft
5%
Kidney Function
5%
Immune Checkpoint Inhibitor
5%
Apoplexy
5%
Squamous Cell Carcinoma
5%
Antiviral Drug
5%
Nonalcoholic Fatty Liver
5%
Mouth Squamous Cell Carcinoma
5%